Alnylam Pharmaceuticals EPS Diluted from Other Gain/Loss (Quarterly) Insights

Alnylam Pharmaceuticals, Inc. (ALNY)

394.24 -18.39 (-4.46%) USD | NASDAQ | Dec 12, 15:22

View EPS Diluted from Other Gain/Loss (Quarterly) for ALNY.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Other Gain/Loss (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

Start Trial